$5.370
-0.059 (-1.10%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ARMP Prediction & Forecast by Similar Chart Analysis
Alphio's ARMP stock price prediction model matches the current Armata Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.40 (+0.63%). The 1-week path is $5.22 (-2.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Armata Pharmaceuticals, Inc. Stock?
Armata Pharmaceuticals Inc. is a good buy right now due to its current price of $5.37 and a recent RSI of 61.236, indicating bullish momentum. The stock has shown a significant 110.59% increase over the past year, reflecting strong growth potential. Furthermore, the company has secured $28.7 million in funding to support its Phase 3 clinical study, which enhances its prospects. However, a key risk is its negative net income of -115,346,000 USD for Q1 2026, which highlights ongoing financial challenges.
ARMP stock price ended at $5.37 on Friday, after losing -1.10%
Armata Pharmaceuticals, Inc. (ARMP) last closed at $5.37, losing -1.10%. These facts feed the 1-day and 1-week ARMP price prediction above.
Forecast Drivers
Armata Pharmaceuticals, Inc. (ARMP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ARMP, ranked by similarity.
Seasonality analysis for ARMP
Historically the probability of a positive August return for ARMP is 33.33%. February offers the highest probability of a positive month at 86.21%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ARMP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.88 | $2.24 | $2.29 | -58.26% |
| Sep 2026 | $2.11 | $2.40 | $2.66 | -55.26% |
| Oct 2026 | $2.24 | $2.39 | $2.70 | -55.56% |
| Nov 2026 | $2.11 | $2.50 | $2.64 | -53.53% |
| Dec 2026 | $2.30 | $2.41 | $2.79 | -55.08% |
In 2026, Armata Pharmaceuticals, Inc. (ARMP) is projected to range from $1.88 to $2.79.
Armata Pharmaceuticals, Inc. 2026 monthly forecast
In Aug 2026, Armata Pharmaceuticals, Inc. is projected to average $2.24, with a low of $1.88 and high of $2.29.
In Sep 2026, Armata Pharmaceuticals, Inc. is projected to average $2.40, with a low of $2.11 and high of $2.66.
In Oct 2026, Armata Pharmaceuticals, Inc. is projected to average $2.39, with a low of $2.24 and high of $2.70.
In Nov 2026, Armata Pharmaceuticals, Inc. is projected to average $2.50, with a low of $2.11 and high of $2.64.
In Dec 2026, Armata Pharmaceuticals, Inc. is projected to average $2.41, with a low of $2.30 and high of $2.79.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.